The US Food and Drug Administration has released a draft guidance on good clinical practices (GCPs) to improve the design and implementation of Clinical Trials. The goal is to make trials more flexible while maintaining data accuracy and participant safety. These updates aim to promote faster and more efficient clinical trials for the development of […]

The post FDA Updates Recommendations To Modernize Clinical Trials first appeared on World Pharma Today.